Mitigating Antimalarial Resistance Consortium in South-East Africa

Photo: Arne Hoel / World Bank

The MARC SE-Africa consortium aims to better define the extent of antimalarial resistance in SE-Africa and to expedite the sharing of such evidence with National Malaria Programmes and their implementation partners.

Our goal is to protect the efficacy of current first-line malaria treatments, which can help prevent thousands of additional malaria deaths annually.


Are you worried about antimalarial drug resistance?

We are here to help you tackle drug-resistant malaria in our region. Our team is working on:

Network, Landscape and Gap Analysis

Objectives: Find the gaps


Addressing Key Evidence Gaps

Objectives: Fill the gaps


Detailed Action Plan to Respond to Antimalarial Resistance

Objectives: Plan the way forward


Implementation into Policy and Practice

Objectives: Make it all happen (and check if it works)


Project Management, Communication and Dissemination

Objectives: Support the consortium, explain the project, make its results widely known


We can provide technical support to your country.

We can help with:

  • developing a costed regional action plan to respond promptly to emerging antimalarial drug resistance

  • updating and disseminating malaria treatment guidelines

  • ensuring you are part of the fight against antimalarial drug resistance

If you are interested in working with us, get in touch.

Prof Karen I Barnes

University of Cape Town (UCT) Collaborating Centre for Optimising Antimalarial Therapy (CCOAT)

Email: marcseafrica@uct.ac.za